Evidence map›Paper›PMID 35779971›Full record

ArticleFertility and sterility2022

Data-driven commentary on SARS-CoV-2 infection, vaccination, and fertility.

Sigal Klipstein, Jodie A Dionne, Eve C Feinberg, Jennifer F Kawwass, Samantha M Pfeifer, Peter N Schlegel, Catherine Racowsky

Open access · bronzeAbstract readComment
In one paragraph

Article in Fertility and sterility, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 2 countries.

Sigal KlipsteinDepartment of Obstetrics and Gynecology, Pritzker School of Medicine, University of Chicago, Chicago, Illinois; InVia Fertility Specialists, Hoffman Estates, Illinois.
Jodie A DionneDivision of Infectious Diseases, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama.
Eve C FeinbergDivision of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
Jennifer F KawwassDivision of Reproductive Endocrinology & Infertility, Department of Obstetrics and Gynecology, Emory Medical School, Atlanta, Georgia.
Samantha M PfeiferDepartment of Obstetrics and Gynecology, Weill Medical College of Cornell University, New York-Presbyterian Hospital, New York, New York.
Peter N SchlegelDepartment of Urology, Weill Medical College of Cornell University, New York-Presbyterian Hospital, New York, New York.
Catherine RacowskyDepartment of Obstetrics, Gynecology and Reproductive Medicine, Hospital Foch, Suresnes, France. Electronic address: catherine.racowsky@gmail.com.
NewYork–Presbyterian Hospital · USEmory Healthcare · USHôpital Foch · FRNorthwestern University · USUniversity of Alabama at Birmingham · USUniversity of Chicago · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A recent study by Wesselink et al. (Am J Epidemiol. 2022 Jan 20;kwac011. doi: 10.1093/aje/kwac011. Online ahead of print) adds to the growing body of research finding that vaccination for coronavirus disease 2019 (COVID-19) is safe for individuals either seeking pregnancy or who are pregnant. The study's authors found no effect of COVID-19 vaccination on fecundity in a population of individuals with no known infertility who were attempting conception. The finding reinforces the messaging of the American Society for Reproductive Medicine COVID-19 Task Force, the aim of which is to provide data-driven recommendations to individuals contemplating pregnancy in the face of the COVID-19 pandemic. As safe and effective COVID-19 vaccines became available, and with an increasing number of studies showing a heightened risk of severe disease during pregnancy, an important role of the Task Force is to encourage vaccination during the preconceptual window and in early pregnancy. The Task Force supports ongoing research to address gaps in knowledge about safe and effective therapies and preventive measures for individuals contemplating pregnancy and during pregnancy. Such research will help optimize care for reproductive-age individuals in the face of current and future health crises.

Indexed as

COVID-19COVID-19 VaccinesFertilityFemaleHumansPandemicsPregnancySARS-CoV-2VaccinationCOVID-19 VaccinesCOVID-19fertilitypandemicpregnancyvaccinationvaccine hesitancy

Identifiers

PMID35779971
PMCPMC9240985
OpenAlexW4283801590

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.